Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jennifer M Specht
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
104 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cork University Hospital
Cork, Ireland
- Cancer Center-Metro Medical Center Bayamon
Bayamón, Puerto Rico
- Doctors Cancer Center
Manati, Puerto Rico
- Centro Comprensivo de Cancer de Upr
San Juan, Puerto Rico
- San Juan City Hospital
San Juan, Puerto Rico
- San Juan Community Oncology Group
San Juan, Puerto Rico
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Gene Upshaw Memorial Tahoe Forest Cancer Center
Truckee, California, United States
- Bayhealth Hospital Kent Campus
Dover, Delaware, United States
- Genesiscare Usa - Aventura Fp
Aventura, Florida, United States
- Emory Saint Joseph'S Hospital
Atlanta, Georgia, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Grady Health System
Atlanta, Georgia, United States
- Hawaii Cancer Care Inc - Waterfront Plaza
Honolulu, Hawaii, United States
- Hawaii Cancer Care Inc-Liliha
Honolulu, Hawaii, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Queen'S Cancer Cenrer - Pob I
Honolulu, Hawaii, United States
- Queen'S Cancer Center - Kuakini
Honolulu, Hawaii, United States
- Queen'S Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital
Honolulu, Hawaii, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Wilcox Memorial Hospital and Kauai Medical Clinic
Lihue, Hawaii, United States
- Hawaii Cancer Care - Westridge
‘Aiea, Hawaii, United States
- Pali Momi Medical Center
‘Aiea, Hawaii, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, United States
- Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, United States
- Northwestern University
Chicago, Illinois, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Northwestern Medicine Cancer Center Kishwaukee
DeKalb, Illinois, United States
- Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Carle Physician Group-Effingham
Effingham, Illinois, United States
- Northwestern Medicine Cancer Center Delnor
Geneva, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Sept 2020
- Primary completion
- 31 Aug 2027
- Completion
- 31 Aug 2027
- Last update posted
- 10 Jul 2026
- Registered enrollment
- 138
- Registry id
- NCT04316117
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.